We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News   Feb 23, 2018 | Original story from University of North Carolina Lineberger

 
Investigational Drug for Melanoma Shows Promise in Early-Stage Study

Effect of MK-8353 on pERK protein levels in normal epidermis in the MK-8353-001 study. Credit: doi:10.1172/jci.insight.92352.

 
 
 

RELATED ARTICLES

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

Cancer Vaccine Progress: Potentially Rich Source of Tumor Specific Antigens Identified

News

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE